Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute is a clinical research site located in Lancaster, Pennsylvania, United States 17601.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral Neoplasms.
Sponsors: Eli Lilly and Company.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral Neoplasms.
Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.